CBMR, Centre for Biomedical Research, University of Algarve, Edificio 2, Ala Norte, University of Algarve, 8005-139, Faro, Portugal.
Epigenetics and Human Disease Laboratory, Department of Biomedical Sciences and Medicine, University of Algarve, Faro, Portugal.
Virchows Arch. 2018 May;472(5):705-715. doi: 10.1007/s00428-018-2348-7. Epub 2018 Apr 6.
Laryngeal biopsies, contrary to biopsies from many other sites of the body, very often contain minute amounts of tumour tissue that may consist of morphologically undifferentiated tumour only. In haematoxylin- and eosin-stained sections, there may be no indicative features of what specific tumour entity that is present. In the larynx, particularly small round cell neoplasms, primary or metastatic, often cause a diagnostic dilemma and where an incorrect diagnosis can induce substantial clinical consequences for the patient (e.g., primary neuroendocrine carcinomas vs metastatic variants, certain sarcomas). If sufficient/representative material has been obtained, the application of immunohistochemistry and/or molecular techniques should in virtually every case reveal the true nature of the malignancy. In cases with sparse amount of material, and therefore a limited number of sections to be cut, a careful and thoughtful stepwise approach is necessary to ascertain a reliable diagnosis, or at least guide the clinician to the most likely diagnoses. With today's advanced and widely available technology with an abundance of markers to discriminate different tumours, the use of the term "undifferentiated" should be largely unnecessary. In the exceptional, and indeed exceedingly rare cases, when a classification is not possible, even after repeat biopsy, we suggest that the laryngeal neoplasm is better termed "unclassified malignant neoplasm" rather than "undifferentiated malignant neoplasm".
与身体其他许多部位的活检不同,喉部活检常常只包含极少量的肿瘤组织,这些组织可能仅由形态上未分化的肿瘤组成。在苏木精和伊红染色的切片中,可能没有任何特征表明存在特定的肿瘤实体。在喉部,特别是小圆细胞肿瘤,无论是原发性还是转移性的,常常导致诊断上的困境,错误的诊断可能会给患者带来实质性的临床后果(例如,原发性神经内分泌癌与转移性变体、某些肉瘤)。如果获得了足够/有代表性的材料,免疫组织化学和/或分子技术的应用几乎在每种情况下都能揭示恶性肿瘤的真实性质。在材料稀少的情况下,也就是可用于切片的数量有限,因此需要谨慎而周到的逐步方法来确定可靠的诊断,或者至少为临床医生提供最可能的诊断方向。有了当今广泛可用的先进技术和大量用于区分不同肿瘤的标志物,“未分化”一词的使用应该在很大程度上是不必要的。在极少数情况下,即使进行了重复活检,仍然无法进行分类,我们建议将喉部肿瘤更好地称为“未分类恶性肿瘤”,而不是“未分化恶性肿瘤”。